SCHEMBL6990429

SCHEMBL6990429

Clc1ccc2c(c1)SCc1cccnc1C2N1CCNCC1

nearest known ligand 0.70

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FNTA P49354 13/20 0.70
FNTB P49356 13/20 0.70
HRAS P01112 1/20 0.45
KRAS P01116 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6995719 0.84 FNTA (0.57) FNTAFNTB
SCHEMBL6995717 0.84 FNTA (0.57) FNTAFNTB
SCHEMBL7000838 0.83 FNTA (1.00) FNTAFNTB
SCHEMBL4692739 0.82 FNTA (1.00) FNTAFNTBHRASKRAS
SCHEMBL9207014 0.82 FNTA (0.75) FNTAFNTBHRASKRAS
SCHEMBL9563131 0.80 FNTA (0.78) FNTAFNTBHRASKRAS
SCHEMBL7000549 0.79 FNTA (1.00) FNTAFNTBHRASKRAS
SCHEMBL7000351 0.79 FNTA (0.71) FNTAFNTBHRASKRAS
SCHEMBL6991223 0.78 FNTA (0.52) FNTAFNTB
SCHEMBL6998378 0.77 FNTA (0.68) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021448-B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORP (US) 2003-05-02 EP disclosed
US-6130229-A Tricyclic compounds having activity as RAS-FPT inhibitors SCHERING CORPORATION (US) 2000-10-10 US disclosed
EP-1021448-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORPORATION (US) 2000-07-26 EP disclosed
WO-1998015556-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORPORATION (US) 1998-04-16 WO disclosed
EP-0535152-B1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylene and piperazine compounds as PAF antagonists and compositions thereof. SCHERING CORP (US) 1995-08-09 EP disclosed
US-5430032-A Treating asthma, allergy, inflammation SCHERING CORPORATION (US) 1995-07-04 US disclosed
US-5422351-A Antiallergens; antiinflammatory agents SCHERING CORPORATION (US) 1995-06-06 US disclosed
EP-0595989-A1 BENZOPYRIDO PIPERYLIDENE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1994-05-11 EP disclosed
EP-0535152-A1 BIS-BENZO OR BENZOPYRIDO CYCLO HEPTA PIPERIDENE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS AND COMPOSITIONS. SCHERING CORP (US) 1993-04-07 EP disclosed
WO-1993002081-A1 NOVEL BENZOPYRIDO PIPERYLIDENE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1993-02-04 WO disclosed
EP-0524784-A1 Benzopyrido piperidylidene compounds as PAF antagonists SCHERING CORPORATION (US) 1993-01-27 EP disclosed
WO-1992000293-A1 BIS-BENZO OR BENZOPYRIDO CYCLO HEPTA PIPERIDENE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1992-01-09 WO disclosed